NSWIn ForceRegulation
Poisons and Therapeutic Goods Regulation 2008
174ERecording of information by pharmacists
Start here
Get a plain-English read of 174E
Turn the raw legal text into a practical explanation grounded in Poisons and Therapeutic Goods Regulation 2008.
#### 174E Recording of information by pharmacists
174E Recording of information by pharmacists
> > (1) This clause applies to a pharmacist who uses an electronic dispensing system that is connected to a prescription exchange service operated by a data source entity.
>
> > (1A) A pharmacist who supplies a monitored medicine must, for the purposes of the database, record the following information about the person who is supplied the medicine—
> >
> > > (a) full name,
> >
> > > (b) date of birth,
> >
> > > (c) street address.
>
> > (2) A pharmacist who supplies a monitored medicine may, for the purposes of the database, record—
> >
> > > (a) the following information about the person who is supplied a monitored medicine—
> > >
> > > > (i) gender,
> > >
> > > > (ii) healthcare identifier,
> > >
> > > > (iii) other relevant information approved by the Secretary,
> > >
> > > > (iv)–(v) (Repealed)
> >
> > > (b) the following information about the pharmacist—
> > >
> > > > (i) full name,
> > >
> > > > (ii) registration number or code recorded in the national register under section 225(c) of the [Health Practitioner Regulation National Law (NSW)](/view/html/inforce/current/act-2009-86a),
> > >
> > > > (iii) healthcare identifier,
> > >
> > > > (iv) other relevant contact information, including telephone number and email address,
> >
> > > (b1) the following information about the business from which the monitored medicine was supplied—
> > >
> > > > (i) healthcare identifier,
> > >
> > > > (ii) business name and address,
> > >
> > > > (iii) other relevant information approved by the Secretary,
> >
> > > (c) the following additional information—
> > >
> > > > (i) the date on which the monitored medicine was supplied,
> > >
> > > > (ii) (Repealed)
> > >
> > > > (iii) the prescription reference number for the prescription under which the monitored medicine was supplied.
>
> **cl 174E:** Ins 2021 (134), Sch 1\[1\]. Am 2022 (194), Sch 1.1\[11\]–\[14\], Sch 1.2\[6\] \[7\].